Natco Pharma's Q4 net profit more than doubles at Rs 177 cr

G Naga Sridhar Hyderabad | Updated on January 12, 2018 Published on May 30, 2017

Natco Pharma Ltd’s consolidated net profit more than doubled at Rs 177 crore in the fourth quarter ended March 31, 2017 compared to Rs 63 crore in the corresponding quarter of the previous financial year.

The total revenue of the Hyderabad-based company grew by 46.2 per cent at Rs 577 crore as against Rs 395 crore in the year-ago period.

For the year ended March 2017 too, net profit more than doubled at Rs 486 crore (Rs 157 crore). The revenue went up by 91 per cent at Rs 2,079 crore (Rs 1,090 crore).

"The revenue and profit growth for the company during the financial year was driven primarily by the sales of generic Oseltamivir product in the US market and continued growth domestic formulations business,’’ the company said in a release issued here on Tuesday.

Natco Pharma’s scrip gained 5.70 per cent on the Bombay Stock Exchange on Tuesday to end at Rs 939.65.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on May 30, 2017
This article is closed for comments.
Please Email the Editor